Upregulation of thrombomodulin expression by activation of farnesoid X receptor in vascular endothelial cells

European Journal of Pharmacology

Volumn 718, Issue 1-3, 2013, Pages 283-289

  He, Xie ^a   Xu, Zhizhen ^a   Wang, Bin ^a   Zheng, Yingru ^b   Gong, Wei ^a   Huang, Gang ^a   Zhang, Li ^a   Li, Yuan ^a   He, Fengtian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Farnesoid X receptor; Gene regulation; Inflammation; Thrombomodulin; Vascular endothelial cell

Indexed keywords

FARNESOID X RECEPTOR; THROMBOMODULIN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG TARGETING; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TM GENE; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR ENDOTHELIUM;

FARNESOID X RECEPTOR; GENE REGULATION; INFLAMMATION; THROMBOMODULIN; VASCULAR ENDOTHELIAL CELL;

HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; THROMBOMODULIN; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84887083722     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.08.020     Document Type: Article

References (48)

1. R.A. Ahmed, K. Murao, H. Imachi, X. Yu, J. Li, N.C. Wong, and T. Ishida Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes Endocrine 35 2009 233 242
2. M. Ananthanarayanan, N. Balasubramanian, M. Makishina, D.J. Mangelsdorf, and F.J. Suchy Human bile salt export pump promoter is transctivated by the farnesoid X recepotor/bile acid receptor Journal of Biological Chemistry 276 2001 28857 28865
3. D. Bishop-Bailey, D.T. Walsh, and T.D. Warner Expression and activation of the farnesoid X receptor in the vasculature Proceedings of the National Academy of Sciences of the United States of America 101 2004 3668 3673
4. H.K. Chong, A.M. Infante, Y.K. Seo, T.I. Jeon, Y. Zhang, P.A. Edwards, X. Xie, and T.E. Osborne Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1 Nucleic Acids Research 38 2010 6007 6017
5. W.A. Dittman, and P.W. Majerus Structure and function of thrombomodulin: a Natural anticoagulant Blood 75 1990 329 336
6. M.C. Edward Thrombomodulin and its role in inflammation Seminars in Immunopathology 34 2011 107 125
7. C.T. Esmon Inflammation and thrombosis Journal of Thrombosis and Haemostasis 1 2003 1343 1348
8. C.T. Esmon Protein C anticoagulant system-anti-inflammatory effects Seminars in Immunopathology 34 2012 127 132
9. S. Fiorucci, G. Rizzo, E. Antonelli, B. Renga, A. Mencarelli, L. Riccardi, A. Morelli, M. Pruzanski, and R. Pellicciari Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis Journal of Pharmacology and Experimental Therapeutics 315 2005 58 68
10. R.M. Gadaleta, K.J. van Erpecum, B. Oldenburg, E.C. Willemsen, W. Renooij, S. Muzilli, L.W. Klomp, P.D. Siersema, M.E Schipper, S. Danese, G. Penna, G. Laverny, L. Adorini, A. Moschetta, and S.W. van Mil Farnesoid X recptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Gut 60 2011 463 472
11. M. Gao, Z.X. Hu, Y.R. Zheng, Y.J. Zeng, X.D. Shen, D. Zhong, and F.T. He Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1 Shock 36 2011 228 234
12. B. Goodwin, S.A. Jones, R.R. Price, M.A. Watson, D.D. Mckee, L.B. Moore, C. Galardi, J.G. Wilson, M.C. Lewis, and M.E. Roth A regulatory cascade of the nuclear receptors FXR, SHP-1. and LRH-1 represses bile acid biosynthesis Molecular Cell 6 2000 517 526
13. J. Grober, I. Zaghini, H. Fujii, S.A. Jones, S.A. Kliever, T.M. Willson, T. Ono, and P. Besnard Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene Journal of Biological Chemistry 274 1999 29749 29754
14. E. Halilbasic, A. Baghdasaryan, and M. Trauner Nuclear receptors as drug targets in cholestatic liver diseases Clinical Liver Disease 17 2013 161 189
15. FT. He, J. Li, Y. Mu, R. Kuruba, Z. Ma, A. Wilson, S. Alber, Y. Jiang, T. Stevens, S. Watkins, B. Pitt, W. Xie, and S. Li Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells Circulation Research 98 2006 192 199
16. D.A.A. Hollman, A. Milona, K.J Erpecum, and S.W.C. Van., Mil Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms Biochimica et Biophysica Acta 1821 2012 1443 1452
17. S. Horie, H. Ishii, F. Matsumoto, M. Kusano, K. Kizaki, J. Matsuda, and M. Kazama Acceleration of thrombomodulin gene transcription by retinoic acid: retinoic acid receptors and Sp1 regulate the promoter activity through interactions with two different sequences in the 5'-flanking region of human gene Journal of Biological Chemistry 276 2001 2440 2450
18. G. Huang, Y.C. Yang, Z.Z. Xu, P. Zhou, W. Gong, Y. Li, J.S. Fan, and F.T. He Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB. European Journal of Pharmacology 650 2011 451 457
19. Z. Hu, L. Ren, and C. Wang Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed wistar rats Kidney and Blood Pressure Research 36 2012 85 97
20. A.V.D. Jabba, F.P.B. Jimmy, M.H. Louis, and C.N.R. Patrick Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis Atherosclerosis 2 2013 306 315
21. P. Jordan, and C.S. William Evolving functions of endothelial cells in inflammation Kidney and Blood Pressure Research 7 2007 803 815
22. W.F. Joseph, C.D. Natalia, J.G. William, C.C. Vipul, and R.E. Elazer Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis International Journal of Cancer 133 2013 1334 1344
23. I. Kim, K. Morimura, Y. Shah, Q. Yang, J.M. Ward, and F.J. Gonzalez Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice Carcinogenesis 28 2007 940 946
24. B.A. Laffitte, H.R. Kast, C.M. Nguyen, A.M. Zavacki, D.D. Moore, and P.A. Edwards Identification of the DNA binding specificity and potential target gens for the farnesoid X-activated receptor Journal of Biological Chemistry 275 2000 10638 10647
25. D. Li, K. Chen, N. Sinha, X. Zhang, Y. Wang, A.K. Sinha, F. Romeo, and J.L. Mehta The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation Cardiovascular Research 65 2005 907 912
26. J. Li, A. Wilson, R. Kuruba, Q. Zhang, X. Gao, F. He, L.M. Zhang, B.R. Pitt, W. Xie, and S. Li FXR-mediated regulation of eNOS expression in vascular endothelial cells Cardiovascular Research 77 2008 169 177
27. Y.T. Li, K.E. Swales, G.J. Thomas, T.D. Warner, and D. Bishop-Bailey Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration Arteriosclerosis, Thrombosis, and Vascular Biology 27 2007 2606 2611
28. D. Lopez, and M.P. MuLean Activation of the rat scavenger receptor class B type I gene by PPAR alpha Molecular Cell Endocrinol 251 2006 67 77
29. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk, M.V. Hull, K.D. Lustig, D.J. Mangelsdorf, and B. Shan Identification of a nuclear receptor for bile acids Science 284 1999 1362 1365
30. P.R. Maloney, D.J. Parks, C.D. Haffner, A.M. Fivush, G. Chandra, K.D. Plunket, K.L. Creech, L.B. Moore, J.G. Wilson, M.C. Lewis, S.A. Jones, and T.M. Willson Identification of a chemical tool for the orphan nuclear receptor FXR Journal of Medicinal Chemistry 43 2000 2971 2974
31. S. Mangan, P. Clancy, and J. Golledge Modulation of endothelial cell thrombomodulin by PPAR ligands-variation according to environment Thrombosis Research 121 2008 827 834
32. D.J. Mangelsdorf, and R.M. Evans The RXR heterodimers and orphan receptors Cell 83 1995 841 850
33. K.E. Matsukuma, M.K. Bennett, J.S. Huang, L. Wang, G. Gil, and T.F. Osborne Coordinated control of bile acids and lipogenesis through FXR-dependent regulation o f fatty acid synthase Journal of Lipid Research 47 2006 2754 2761
34. J. Morser Thrombomodulin links coagulation to inflammation and immunity Current Drug Targets 13 2012 421 431
35. W.G. Owen, and C.T. Esmon Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Journal of Biological Chemistry 256 1981 5532 5535
36. T.I. Pineda, T. Claudel, C. Duval, V. Kosykh, J.C. Fruchart, and B. Staels Bile acids induce the expression of the human peroxisome proliferator-actiated receptor alpha gene via activation of the farnesoid X receptor Molecular Endocrinology 17 2003 259 272
37. M. Podvinec, M.R. Kaufmann, C. Handschin, and U.A. Meyer NUBIScan, an in silico approach for predication of nuclear receptor response elements Molecular Endocrinology 16 2002 1269 1279
38. H.H. Salem, I. Maruyama, H. Ishii, and P.W. Majerus Isolation and characterization of thrombomodulin from human placenta Journal of Biological Chemistry 259 1984 12246 12251
39. C.S. Song, I. Echchgadda, B.S. Baek, S.C. Ahn, T. Oh, A.K. Roy, and B. Chatterjee Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor Journal of Biological Chemistry 276 2001 42549 42556
40. O. Takayuki, T. Hironobu, S. Koji, and S. Motomu Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis Critical Care Research and Practice 2012 2012 1155 1165
41. M. Tsiang, S.R. Lentz, and J.E. Sadler Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity Journal of Biological Chemistry 267 1992 6164 6170
42. N.L. Urizar, A.B. Liverman, D.T. Dodds, F.V. Silva, P. Ordentlich, Y. Yan, F.J. Gonzalez, R.A. Heyman, D.J. Mangelsdorf, and D.D. Moore A natural product that lowers cholesterol as an antagonist ligand for FXR Science 296 2002 1703 1706
43. X.X. Wang, T. Jiang, Y. Shen, A. Luciano, P. Mark, J.G. Frank, S. Pnina, L. Linda, M-A. Shinobu, and L. Moshe The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria American Journal of Physiology: Renal Physiology 297 2009 F1587 F1596
44. Y.D. Wang, W.D. Chen, M. Wang, D. Yu, B.M. Forman, and W. Huang Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response Hepatology 48 2008 1632 1643
45. P.J. Willy, K. Umesono, E.S. Onq, R.M. Evans, R.A. Heyman, and D.J. Mangelsdorf LXR, a nuclear receptor that defines a distinct retinoid response pathway Genes and Development 9 1995 1033 1045
46. J.R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P.E. Kroeger Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells American Journal of Physiology: Renal Physiology 293 2007 F1592 F1604
47. S. Zhang, J. Wang, Q. Liu, J. Wang, and C.H. Douglas Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcohlic steatohepatitis Journal of Hepatology 51 2009 380 388
48. G. Zollner, M. Wagner, P. Fickert, A. Geier, A. fuchsbichler, D. Silbert, J. Gumhold, K. Zatloukal, A. Kaser, H. Tilg, H. Denk, and M Trauner Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver American Journal of Physiology: Gastrointestinal and Liver Physiology 289 2005 G798 G805